TELA Bio Appoints Renowned Surgeon as Vice President of Clinical Development

Bruce Freedman, M.D. joins innovative MedTech company to advocate for more natural surgical hernia mesh options

MALVERN, PA — TELA Bio, Inc. (Nasdaq: TELA), an innovative MedTech company focused on advancing the field of soft-tissue reconstruction, announced that it has welcomed Bruce Freedman, M.D., FACS as Vice President of Clinical Development. After 32 years as a private practice general surgeon specializing in hernia repair and abdominal wall reconstruction, Dr. Freedman has joined TELA Bio to advocate for a more natural hernia repair mesh option as an alternative to permanent and resorbable synthetic mesh.

“As a surgeon who has performed thousands of hernia repairs with plastic mesh over the past three decades, I fully understand the clinical limitations of using synthetic mesh to repair human tissue,” said Dr. Freedman. “Unfortunately, plastic mesh has the potential to create a foreign body response and inflammation in some patients, the effects of which can cause complications immediately after surgery or even many years down the road. OviTex® is a very different material and was designed specifically to reduce this foreign-body response. As I incorporated it in my practice, I saw first-hand how the careful work that went into the design positively impacted my patients.” He added, “TELA Bio is providing much needed innovation in the hernia repair specialty, and I believe this product has remarkable potential to help surgeons break decades-long dependence on plastic mesh, while advancing treatment and better serving the patient.”

READ:  Verrica Pharmaceuticals Holds Type A Meeting with FDA for VP-102 for Molluscum Contagiosum

In his role, Dr. Freedman will be using his extensive experience as a healthcare provider to share the clinical and financial benefits of the OviTex Reinforced Tissue Matrix portfolio with surgeons and hospital administration. “TELA Bio has spent the past several years working closely with surgeons in capturing and documenting clinical and financial evidence. They’ve got a powerful message, one I’m enthusiastic to help spread,” Dr. Freedman added.

“We are thrilled to welcome Dr. Freedman to our team. Improving patient access to our innovative technology requires education throughout the healthcare delivery system, which includes surgeons, clinical resources, supply chain, hospital administrators, and patients,” said Antony Koblish, Co-founder, President, and Chief Executive Officer, TELA Bio. “Dr. Freedman adds a credible, experienced voice that will help distinguish us from the many larger, legacy companies. Like us, he shares a passion for safer hernia repair and his decision to join our mission further reinforces the critical need to offer patients a more natural hernia repair.”

READ:  Donegal Insurance Group Taps David Sponic to Lead Personal Lines Division

To find practicing surgeons throughout the country who believe in providing patients with a more natural hernia repair option, click here.

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.